A Randomised Controlled Trial of High Dose, Inhaled Budesonide Versus Oral Prednisone in Patients Discharged from the Emergency Department following an Acute Asthma Exacerbation | Zendy

J. Mark FitzGerald | Zendy; David Shragge | Zendy; Jennifer Haddon | Zendy; Barbara Jennings | Zendy; Joanna Lee M Math | Zendy; Tony R. Bai | Zendy; Peter D. Paré | Zendy; David Kassen | Zendy; Anton Grunfeld | Zendy

Open Access

A Randomised Controlled Trial of High Dose, Inhaled Budesonide Versus Oral Prednisone in Patients Discharged from the Emergency Department following an Acute Asthma Exacerbation

Author(s) -

J. Mark FitzGerald,

David Shragge,

Jennifer Haddon,

Barbara Jennings,

Joanna Lee M Math,

Tony R. Bai,

Peter D. Paré,

David Kassen,

Anton Grunfeld

Publication year - 2000

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2000/587957

Subject(s) - medicine , emergency department , prednisone , budesonide , exacerbation , asthma , asthma exacerbations , emergency medicine , randomized controlled trial , anesthesia , psychiatry

Prednisone (PRED) is recommended at discharge to reduce the relapse rate following emergency treatment for an asthmatic attack. However, PRED has systemic side effects. Inhaled anti-inflammatory medications, such as budesonide (BUD), are well tolerated. This study was designed to compare the effectiveness of PRED and BUD on relapse rate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research